Breast Cancer Research

official impact factor 5.79

Commentary

An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)

Georgia Chenevix-Trench1*, Roger L Milne2, Antonis C Antoniou3, Fergus J Couch4, Douglas F Easton3, David E Goldgar5 and CIMBA

Author Affiliations

1 Queensland Institute for Medical Research, Brisbane, Australia

2 Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain

3 CR-UK Genetic Epidemiology Unit, University of Cambridge, Cambridge, UK

4 Mayo Clinic College of Medicine, Rochester, Minnesota, USA

5 Department of Dermatology, University of Utah, Salt Lake City, Utah, USA

For all author emails, please log on.

Breast Cancer Research 2007, 9:104 doi:10.1186/bcr1670

Published: 19 April 2007

Additional files

Additional file 1:

Current contributors to CIMBA

Format: DOC Size: 38KB Download file

This file can be viewed with: Microsoft Word Viewer